News

The Impact Journals news page hosts content about important news articles and press releases from our Journals and Editorial Board Members.

News

Mission
The Impact Journals news page hosts articles about important news stories from our journals and within the scientific community. Visit this page for the latest in medical advances, pharmaceutical progress, conference reports, and more.

Oncotarget | The serine protease matriptase inhibits migration and proliferation in multiple myeloma cells

News

November 7, 2022
PRESS RELEASE: A new research paper was published in Oncotarget's Volume 13 on October 20, 2022, entitled, “The serine protease matriptase inhibits migration and proliferation in multiple myeloma cells.” continue reading »

Aging | Rapamycin treatment early in life reprograms aging: hyperfunction theory and clinical practice

Aging

November 3, 2022
PRESS RELEASE: A new research perspective was published on October 24, 2022, in Aging's Volume 14, Issue 20, entitled, “Rapamycin treatment early in life reprograms aging: hyperfunction theory and clinical practice.” continue reading »

Oncotarget | Nectin-4 is widely expressed in head and neck squamous cell carcinoma

Oncotarget

November 3, 2022
PRESS RELEASE: A new research paper was published in Oncotarget's Volume 13 on October 20, 2022, entitled, “Nectin-4 is widely expressed in head and neck squamous cell carcinoma.” continue reading »

Aging | Downregulation of senescence-associated secretory phenotype by knockdown of secreted frizzled-related protein 4 contributes to the prevention of skin aging

Aging

October 31, 2022
PRESS RELEASE: A new research paper was published on the cover of Aging's Volume 14, Issue 20, entitled, “Downregulation of senescence-associated secretory phenotype by knockdown of secreted frizzled-related protein 4 contributes to the prevention of skin aging.” continue reading »

Oncotarget is Again on MEDLINE

News

October 27, 2022
PRESS RELEASE: On September 15, 2022, Oncotarget was accepted again for indexing by MEDLINE. Oncotarget is now indexed by MEDLINE/PubMed and PubMed Central/PubMed. continue reading »